First Manhattan’s Veracyte VCYT Stock Holding History

First Manhattan’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-6	Closed	-$133	–	1577
2023 Q3	$133	Buy	+6	New	+$154	﹤0.01%	1450
2018 Q2	–	Sell	-272,700	Closed	-$1.52M	–	1422
2018 Q1	$1.52M	Hold	272,700	–	–	0.01%	383
2017 Q4	$1.78M	Buy	+272,700	New	+$2.03M	0.01%	381

Other funds holding VCYT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

First Manhattan's VCYT Position: Q4 2023 in Review

First Manhattan sold out of Veracyte (VCYT) in Q4 2023, closing a stake of 6 shares — an estimated $133 sold.

First Manhattan first reported a position in VCYT in Q4 2017 and held it in 3 quarters. The position peaked at $1.78M in Q4 2017. 250 funds tracked by Wall St. Rank hold VCYT as of Q4 2023.

First Manhattan reported no remaining Veracyte position as of Q4 2023 after selling out during the quarter.
First Manhattan sold 6 Veracyte shares in Q4 2023, an estimated $133.
First Manhattan first reported a position in Veracyte in Q4 2017 and held it in 3 quarters.
First Manhattan's Veracyte position peaked at $1.78M in Q4 2017.
250 funds tracked by Wall St. Rank held Veracyte as of Q4 2023.

Based on First Manhattan's 13F filing for Q4 2023, filed 13 Feb 2024.